HPQ Stock Analysis: HP | NYSE
Computer Hardware | NYSE, USA | Market Cap: 28.082m USD | 12M Return: 27.5% | US40434L1052 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 500M
EPS Trend: -27.3%
Qual. Beats: 3
Rev. Trend: 89.4%
Qual. Beats: 3
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
HP Inc. (NYSE: HPQ) is a global Information Technology company operating in the Technology Hardware, Storage & Peripherals sub-industry. Founded in 1939 and headquartered in Palo Alto, California, the company was renamed from Hewlett-Packard in October 2015. It operates through three segments: Personal Systems (commercial and consumer PCs, workstations, displays, and related services), Printing (consumer and commercial printer hardware, supplies, and 3D printing solutions), and Corporate Investments (business incubation and investment projects). Its customer base spans small- and medium-sized businesses, the public sector, and large enterprises across the United States and international markets.
The companys business model is anchored in two core hardware franchises-personal computers and printing-supplemented by services and emerging areas such as 3D printing and hybrid work solutions. The printing segment in particular follows a razor-and-blade model, generating recurring revenue through the sale of consumables like ink and toner that complement its installed base of printer hardware. As a Large Cap in a mature and cyclical sector, HPQs results are closely tied to corporate and consumer IT spending, refresh cycles for PCs, and demand for printing supplies.
- PC demand recovery boosts Personal Systems revenue
- Printing supplies margins pressured by aftermarket competition
- AI PC cycle drives commercial notebook refresh
- Capital return through buybacks and dividends continues
| Net Income: 2.45b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 1.36 > 1.0 |
| NWC/Revenue: -12.20% < 20% (prev -13.32%; Δ 1.13% < -1%) |
| CFO/TA 0.10 > 3% & CFO 4.67b > Net Income 2.45b |
| Net Debt (7.35b) to EBITDA (4.27b): 1.72 < 3 |
| Current Ratio: 0.79 > 1.5 & < 3 |
| Outstanding Shares: last quarter (927.0m) vs 12m ago -2.83% < -2% |
| Gross Margin: 19.87% > 18% (prev 20.89%; Δ -1.02% > 0.5%) |
| Asset Turnover: 138.3% > 50% (prev 137.3%; Δ 1.02% > 0%) |
| Interest Coverage Ratio: 7.89 > 6 (EBIT TTM 3.34b / Interest Expense TTM 423.0m) |
| A: -0.16 (Total Current Assets 26.7b - Total Current Liabilities 34.0b) / Total Assets 45.7b |
| B: -0.05 (Retained Earnings -2.12b / Total Assets 45.7b) |
| C: 0.08 (EBIT TTM 3.34b / Avg Total Assets 42.8b) |
| D: -0.00 (Book Value of Equity -92.0m / Total Liabilities 45.8b) |
| Altman-Z'' = -0.66 = B |
| DSRI: 1.29 (Receivables 10.8b/7.72b, Revenue 59.2b/54.7b) |
| GMI: 1.05 (GM 20.89% / 19.87%) |
| AQI: 0.85 (AQ_t 0.32 / AQ_t-1 0.38) |
| SGI: 1.08 (Revenue 59.2b / 54.7b) |
| TATA: -0.05 (NI 2.45b - CFO 4.67b) / TA 45.7b) |
| Beneish M = -2.78 (Cap -4..+1) = A |
As of October 04, 2026, the stock is trading at USD 32.12 with a total of 10,286,954 shares traded. Over the past week, the price has changed by +2.62%, over one month by +1.38%, over three months by +47.89% and over the past year by +27.48%.
Current recommended Stop Loss: 29.40 (which is 8.5% or 1.9 ATR below the current price).
HP has received a consensus analysts rating of 3.24. Therefore, it is recommended to hold HPQ.
- StrongBuy: 2
- Buy: 2
- Hold: 12
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 29.7 | -7.7% |
P/E Trailing = 12.2598
P/E Forward = 9.9206
P/S = 0.4747
P/B = 0.6074
P/EG = 3.4205
Revenue TTM = 59.2b USD
EBIT TTM = 3.34b USD
EBITDA TTM = 4.27b USD
Long Term Debt = 7.87b USD (from longTermDebt, last quarter)
Short Term Debt = 1.70b USD (from shortTermDebt, last quarter)
Debt = 11.5b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.18b
Net Debt = 7.35b USD (calculated: Debt 11.5b - CCE 4.17b)
Enterprise Value = 35.4b USD (28.1b + Debt 11.5b - CCE 4.17b)
Interest Coverage Ratio = 7.89 (Ebit TTM 3.34b / Interest Expense TTM 423.0m)
EV/FCF = 9.13x (Enterprise Value 35.4b / FCF TTM 3.88b)
FCF Yield = 10.95% (FCF TTM 3.88b / Enterprise Value 35.4b)
FCF Margin = 6.56% (FCF TTM 3.88b / Revenue TTM 59.2b)
Net Margin = 4.14% (Net Income TTM 2.45b / Revenue TTM 59.2b)
Gross Margin = 19.87% ((Revenue TTM 59.2b - Cost of Revenue TTM 47.4b) / Revenue TTM)
Gross Margin QoQ = 18.79% (prev 20.93%)
Tobins Q-Ratio = 0.78 (Enterprise Value 35.4b / Total Assets 45.7b)
Interest Expense / Debt = 3.67% (Interest Expense 423.0m / Debt 11.5b)
Taxrate = 12.34% (345.0m / 2.80b)
NOPAT = 2.93b (EBIT 3.34b * (1 - 12.34%))
Current Ratio = 0.79 (Total Current Assets 26.7b / Total Current Liabilities 34.0b)
Debt / Equity = -125.2 (out of range, set to none) (Debt 11.5b / totalStockholderEquity, last quarter -92.0m)
Debt / EBITDA = 1.72 (Net Debt 7.35b / EBITDA 4.27b)
Debt / FCF = 1.89 (Net Debt 7.35b / FCF TTM 3.88b)
Total Stockholder Equity = -337.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.73% (Net Income 2.45b / Total Assets 45.7b)
RoE = -727.3% (negative equity) (Net Income TTM 2.45b / Total Stockholder Equity -337.0m)
RoCE = 44.34% (EBIT 3.34b / Capital Employed (Equity -337.0m + L.T.Debt 7.87b))
RoIC = 27.93% (NOPAT 2.93b / Invested Capital 10.5b)
WACC = 7.40% (E(28.1b)/V(39.6b) * Re(9.11%) + D(11.5b)/V(39.6b) * Rd(3.67%) * (1-Tc(0.12)))
Discount Rate = 9.11% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.22 | Cagr: -2.88%
[DCF] Terminal Value 77.97% ; FCFF base≈3.47b ; Y1≈3.97b ; Y5≈5.85b
[DCF] Fair Price = 89.42 (EV 88.0b - Net Debt 7.35b = Equity 80.6b / Shares 901.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -27.29 | EPS CAGR: -0.96% | SUE: 1.23 | # QB: 3
Revenue Correlation: 89.41 | Revenue CAGR: 3.46% | SUE: 4.0 | # QB: 3
EPS current Quarter (2027-01-31): EPS=0.70 | Chg30d=+3.11% | Revisions=+18% | Analysts=12
EPS current Year (2026-10-31): EPS=3.24 | Chg30d=+7.51% | Revisions=+81% | GrowthEPS=+4.0% | GrowthRev=+8.2%
EPS next Year (2027-10-31): EPS=3.14 | Chg30d=+4.35% | Revisions=+47% | GrowthEPS=-3.3% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: +61% (up=29, down=6)